Inhibition of the clastogenic effect of cyclophosphamide by WR-2721 in the bone marrow of mice
Authors:
- 1 September 1994
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 309 (2) , 219-223
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Protection by WR-2721 of the toxicity induced by the combination of cisplatin and 5-fluorouracilInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
- Cyclophosphamide ToxicityDrugs, 1991
- Clinical Pharmacokinetics of CyclophosphamideClinical Pharmacokinetics, 1991
- The early history of the biological alkylating agents, 1918–1968Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1990
- Clinical trials of WR-2721 and cis-platinumInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1989
- Pharmacokinetics of WR-2721Pharmacology & Therapeutics, 1988
- Models for thiol protection of DNA in cellsPharmacology & Therapeutics, 1988
- Protection of DNA by thiolsPharmacology & Therapeutics, 1988
- The use of a simple haematoxylin and eosin staining procedure to demonstrate micronuclei within rodent bone marrowMutation Research/Environmental Mutagenesis and Related Subjects, 1986
- Sensitizers and protectors in radiotherapyCancer, 1985